Cited by 516Curcumin's Biomedical ApplicationsAlzheimer's disease research and treatmentsMedicinal Plants and Neuroprotection

Neuroprotective effects of curcumin

Open access
Cole, Greg M., Teter, Bruce, Frautschy, Sally A.·2007·ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY

Abstract

Neurodegenerative diseases result in the loss of functional neurons and synapses. Although future stem cell therapies offer some hope, current treatments for most of these diseases are less than adequate and ourbest hope is to prevent these devastating diseases. Neuroprotective approaches work best prior to the initiation of damage, suggesting that some safe and effective prophylaxis would be highly desirable. Curcumin has an outstanding safety profile and a number of pleiotropic actions with potential for neuroprotective efficacy, including anti-inflammatory, antioxidant, and anti-protein-aggregate activities. These can be achieved at submicromolar levels. Curcumin's dose-response curves are strongly dose dependent and often biphasic so that in vitro data need to be cautiously interpreted; many effects might not be achievable in target tissues in vivo with oral dosing. However, despite concerns about poor oral bioavailability, curcumin has at least 10 known neuroprotective actions and many of these might be realized in vivo. Indeed, accumulating cell culture and animal model data show that dietary curcumin is a strong candidate for use in the prevention or treatment of major disabling age-related neurodegenerative diseases like Alzheimer's, Parkinson's, and stroke. Promising results have already led to ongoing pilot clinical trials.

Integrity signals

Registry

Crossref · 10.1007/978-0-387-46401-5_8

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Curcuma longa is used in treatment of Alzheimer's patients because of its anti-amyloidogenic, antioxidant, and anti-inflammatory activities.

    “Curcuma longa is of the family Zingiberaceae.It is used in the treatment of Alzheimer's patients because of its anti-amyloidogenic, antioxidant, and anti-inflammatory activities [57] .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cole, G. M., Teter, B., & Frautschy, S. A.
Affiliations
VA Sepulveda Ambulatory Care Center (US)
Venue
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
Publisher
Springer US
Published
2007-08-06
Volume
595
Pages
197-212
OpenAlex
W1586405889
Cited by
516
References
92
Citations by year
2026: 14 · 2025: 27 · 2024: 23 · 2023: 33 · 2022: 31 · 2021: 40 · 2020: 47 · 2019: 34 · 2018: 24 · 2017: 30 · 2016: 27 · 2015: 31 · 2014: 24 · 2013: 28 · 2012: 22
FWCI
8.90
Type
book chapter
Language
en
Open access
Locations
  • Springer eBooks (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (U01AG028583, P50AG016570, R01AG013741, R01AG010685)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
curcumin, neuroprotection, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, stroke, anti-inflammatory activity, antioxidant activity, oral bioavailability, dose-response relationship, prophylaxis
MeSH terms
Animals, Curcumin, Dose-Response Relationship, Drug, Humans, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review